Cognition

perspective

Beyond Cost: How to Evaluate CPL Vendors in Pharma and Biotech

Beyond Cost: How to Evaluate CPL Vendors in Pharma and Biotech

When evaluating a Cost-Per-Lead (CPL) vendor in the pharma and biotech space, it’s critical to go beyond basic lead volume and assess their ability to deliver qualified, compliant, and strategically aligned leads that support your commercial and scientific goals.  Here’s a breakdown of what to look for in a pharma/biotech CPL vendor:  🔬 1. Industry …

Beyond Cost: How to Evaluate CPL Vendors in Pharma and Biotech Read More »

Lead Generation for F&B Manufacturers 

Strategies for Improving Lead Generation for F&B Manufacturers 

F&B manufacturers face challenges in lead generation due to complex supply chains, long sales cycles, and evolving market demands. To overcome these, companies must:  Use AI-powered data targeting to identify decision-makers and high-intent prospects.  Strengthen digital presence through SEO, LinkedIn, and industry thought leadership.  Implement personalized outreach using Account-Based Marketing (ABM) to drive engagement and …

Strategies for Improving Lead Generation for F&B Manufacturers  Read More »

B2B Prospecting

The Hidden Data Trap in B2B Prospecting: Why the Data Crackdown is Just the Beginning

The Calm Before the Fracture  A quiet but seismic shift is underway in B2B lead generation—and many organizations don’t yet realize their foundations are starting to crack.  Recent platform enforcement actions have seen major data providers vanish from LinkedIn almost overnight. Tools that fueled thousands of prospecting pipelines – automated scrapers, Chrome extensions, and plug-ins, …

The Hidden Data Trap in B2B Prospecting: Why the Data Crackdown is Just the Beginning Read More »

Revenue Blind Spots

The Revenue Blind Spots: Why Event Companies Are Missing 40% of Their Growth Opportunities

Cognition Solutions analysis reveals some striking patterns in the B2B events landscape: companies achieving record post-pandemic recovery are still missing up to 40% of their revenue potential. This isn’t about untapped markets or new event formats – it’s about Revenue Blind Spots – revenue opportunities hiding in plain sight within existing portfolios. 📊 Three critical …

The Revenue Blind Spots: Why Event Companies Are Missing 40% of Their Growth Opportunities Read More »

ESG in Healthcare Procurement

ESG in Healthcare Procurement: What It Means for Medical Device and MedTech Companies

📉 The $3.8 Billion Wake-Up Call: A Shift in Hospital Procurement In 2023, a major U.S. hospital network canceled over $3.8 billion in long-term supply contracts with medical device manufacturers—not due to cost, but ESG misalignment. The suppliers, while clinically competitive, failed to meet new environmental and labor transparency criteria that the health system had …

ESG in Healthcare Procurement: What It Means for Medical Device and MedTech Companies Read More »

Beyond Drug Discovery: Predictive Analytics for Biotech B2B Lead Generation

Beyond Drug Discovery: Predictive Analytics for Biotech B2B Lead Generation

Revolutionizing Biotech B2B Sales: The Power of Predictive Analytics In a boardroom filled with biotech executives, the conversation is no longer just about groundbreaking therapies—it’s about precision-targeted B2B lead generation. Imagine a world where contract research organizations (CROs), contract manufacturing organizations (CMOs), and biotech investors don’t just stumble upon opportunities but predict and capture them …

Beyond Drug Discovery: Predictive Analytics for Biotech B2B Lead Generation Read More »

Cognition
Scroll to Top